Saxagliptin is a new oral hypoglycemic of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus.
Molecular Weight:
351.87
CAS Number:
[709031-78-7]
Formula:
C18H26ClN3O2
Target:
Proteasome|||Others
T6203L
* VAT and and shipping costs not included. Errors and price changes excepted